Literature DB >> 421204

Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.

S M Cohen, M Arai, J B Jacobs, G H Friedell.   

Abstract

The existence of at least two stages in bladder carcinogenesis was evaluated in male Fischer rats using N-[14-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) fed for six weeks at a level of 0.2% of the diet as the initiator. Sodium saccharin and DL-tryptophan were fed at levels of 5 and 2% of the diet, respectively, as possible promoting chemicals, and they were fed either immediately after FANFT administration or after six weeks of FANFT plus six weeks of control diet. All surviving rats were killed at the end of two years. Both chemicals significantly increased the incidence of bladder tumors following FANFT feeding compared to six weeks of FANFT feeding followed by control diet, and the results were similar whether saccharin or tryptophan feeding was started immediately after FANFT feeding was concluded or after a six-week delay. Saccharin was considerably more potent as a promoting agent than was tryptophan, inducing higher incidences of bladder tumors and having a shorter latent period. Long-term administration of FANFT induced a 100% incidence of bladder cancer. Sequential epithelial changes were observed by scanning and transmission electron microscopy as well as by light microscopy. Pleomorphic microvilli were present on the superficial cells of all tumors examined and on the surface cells of hyperplastic bladder epithelium after six weeks of FANFT plus six weeks of saccharin, but not after six weeks of FANFT and six weeks of control diet. Rats fed only saccharin tryptophan, or control diet did not have bladder tumors or pleomorphic microvilli on bladder epithelium. These data suggest that saccharin and tryptophan might act as tumor-promoting agents during bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421204

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Saccharin and cyclamate inhibit binding of epidermal growth factor.

Authors:  L S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

3.  Urinary cytology in workmen engaged in the petrochemical industry with reference to non-industrial risk factors.

Authors:  H D Adolphs; G Hildenbrand; H W Schwabe; E W Vahlensieck
Journal:  Urol Res       Date:  1985

4.  Effects of tumor promoters, genotoxic carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication.

Authors:  R J Ruch; J E Klaunig
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

5.  12-O-tetradecanoylphorbol-13-acetate induces selective desquamation of superficial cells in rat urinary bladder epithelium.

Authors:  S Watanabe; J Sasaki
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

6.  Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  M A Shibata; K Nakanishi; M Shibata; T Masui; Y Miyata; N Ito
Journal:  Urol Res       Date:  1986

7.  Urothelial carcinogenesis and portocaval anastomosis in the rat.

Authors:  D M Wallace; D Ackermann; B Davis; W H Hartmann
Journal:  Urol Res       Date:  1987

Review 8.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Morphological changes of microvilli on different surfaces of epithelial cells in the rat bladder treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.

Authors:  X Zhang; I Takenaka
Journal:  Urol Res       Date:  1995

10.  Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol.

Authors:  Yasuharu Yazawa; Nobutomo Ikarashi; Motohiro Hoshino; Hironori Kikkawa; Fumiyo Sakuma; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2020-06-01       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.